Read + Share
Hata A, Katakami N, Takase N, Kibata K, et al. Afatinib plus bevacizumab combination after osimertinib resistance in advanced
EGFR-mutant non-small cell lung cancer: Phase II ABCD-study. Lung Cancer 2024;197:107988.
PMID: 39393258
|
 |
|
Hata A, Katakami N, Takase N, Kibata K, et al. Afatinib plus bevacizumab combination after osimertinib resistance in advanced
EGFR-mutant non-small cell lung cancer: Phase II ABCD-study. Lung Cancer 2024;197:107988.
PMID: 39393258
|
|
|
|